- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- January 2026
- 120 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- May 2026
- 350 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- April 2026
- 120 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- May 2026
- 145 Pages
Global
From €3534EUR$3,950USD£3,022GBP
- Report
- December 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- December 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- June 2026
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- October 2025
- 87 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- May 2026
- 250 Pages
Europe
From €3462EUR$3,869USD£2,960GBP
From €4026EUR$4,500USD£3,443GBP
- Report
- November 2023
- 152 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- August 2024
- 143 Pages
Global
From €4161EUR$4,650USD£3,558GBP
- Report
- January 2023
- 152 Pages
Global
From €2013EUR$2,250USD£1,722GBP
- Report
- April 2025
- 120 Pages
Global
From €5324EUR$5,950USD£4,553GBP
- Report
- December 2024
- 100 Pages
United States
From €5324EUR$5,950USD£4,553GBP
- Report
- July 2024
- 110 Pages
North America
From €4429EUR$4,950USD£3,788GBP

Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality.
The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling.
Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more